Literature DB >> 6391762

Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.

I Nath, M Sathish, T Jayaraman, L K Bhutani, A K Sharma.   

Abstract

Evidence for the presence of Mycobacterium leprae reactive T cells in many lepromatous leprosy (LL) patients was obtained using in vitro antigen-induced lymphoproliferative responses. (1) Co-cultures of T enriched cells from LL patients when combined with 2 h adherent cells (AC) from HLA-D compatible tuberculoid leprosy individuals showed significant levels of 3H-thymidine incorporation in the presence of soluble and integral M. leprae antigens. (2) More interestingly, autologous T cell + AC co-cultures also showed significant improvement in antigen-induced lymphoproliferation in nine of 16 lepromatous patients. Insignificant improvement was observed in similar co-cultures of tuberculoid leprosy patients. (3) Addition of exogenous, purified human interleukin-2 (IL-2) to antigen stimulated PBMC from some lepromatous patients showed the best improvement in terms of overall 3H-thymidine incorporation, indicating that lepromatous patients possess T cells which can differentiate to an IL-2 responsive state. Significantly, the level of proliferation varied within the group. A proportion of clinically similar lepromatous patients failed to show improvement by any of the above methods.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391762      PMCID: PMC1577090     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Concanavalin A induced suppressor activity in human leprosy.

Authors:  I Nath; R B Narayanan; N K Mehra; A K Sharma; M D Gupte
Journal:  J Clin Lab Immunol       Date:  1979-11

2.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

3.  Dissociation of effector functions in populations of activated macrophages.

Authors:  E J Wing; I D Gardner; F W Ryning; J S Remington
Journal:  Nature       Date:  1977-08-18       Impact factor: 49.962

4.  Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors.

Authors:  J Andersson; K O Grönvik; E L Larsson; A Coutinho
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

5.  The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.

Authors:  I Nath; R Singh
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

6.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

Review 7.  Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.

Authors:  K C Lee; D Berry
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

8.  Fate of Listeria monocytogenes in murine peritoneal macrophage subpopulations.

Authors:  L Harrington-Fowler; M S Wilder
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

9.  Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.

Authors:  J Convit; N Aranzazu; M Pinardi; M Ulrich
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

10.  Long-term culture of human antigen-specific cytotoxic T-cell lines.

Authors:  S Gillis; P E Baker; F W Ruscetti; K A Smith
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  13 in total

1.  Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.

Authors:  Mehervani Chaduvula; A Murtaza; Namita Misra; N P Shankar Narayan; V Ramesh; H K Prasad; Rajni Rani; R K Chinnadurai; Indira Nath
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.

Authors:  S Barnass; J Mace; J Steele; P Torres; B Gervasoni; R Ravioli; J Terencio; G A Rook; M F Waters
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

3.  Defective intralesional interferon-gamma activity in patients with lepromatous leprosy.

Authors:  B Volc-Platzer; H Stemberger; T Luger; T Radaszkiewicz; G Wiedermann
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

4.  Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.

Authors:  S Laal; L K Bhutani; I Nath
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

5.  Human T cell proliferative responses to particulate microbial antigens are supported by populations enriched in dendritic cells.

Authors:  A Mittal; I Nath
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

6.  Recombinant human interleukin-2 reverses in vitro-deficient cell-mediated immune responses to tuberculin purified protein derivative by lymphocytes of tuberculous patients.

Authors:  H Shiratsuchi; Y Okuda; I Tsuyuguchi
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 7.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.

Authors:  S J Brett; A E Kingston; M J Colston
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

9.  Evidence of cell-mediated immune contrasuppression in lepromatous leprosy: modulation of a putative T contrasuppressor cell-subset.

Authors:  R González-Amaro; J F Salazar-González; L Baranda; C Abud-Mendoza; B Moncada; R García; J Alcocer-Varela
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

10.  The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.

Authors:  Y M Hussein; M A Kerr; J S Beck
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.